Docs Check Mail for Ways to Return — and Ruin — Extra Opioids

Mail carriers could play a key role in reducing opioid misuse, according to researchers and regulators. One strategy under consideration by the US Food and Drug Administration (FDA) would require that opioid analgesics be dispensed with prepaid mail-back envelopes so patients can return leftover medication. Another approach — which is not part of the FDA … Read more

Nursing Board Discriminates Against Those Seeking Opioid Help: DOJ

The US Department of Justice (DOJ) says the Indiana State Nursing Board discriminates against nurses with opioid use disorder (OUD), according to findings of a recently released investigation. Specifically, the board “violated the Americans with Disabilities Act (ADA) by prohibiting nurses who take medication to treat OUD from participating in the Indiana State Nursing Assistance … Read more

FDA, DEA Pushed to Make Gabapentin a Controlled Substance

In a bid to stop abuse and diversion of the anticonvulsant gabapentin, a watchdog group is petitioning federal regulators to make the drug a controlled substance. The nonprofit group Public Citizen has filed a petition with the US Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA), arguing that medication’s risks additional safeguards. … Read more

Mindfulness Intervention Curbs Opioid Misuse, Chronic Pain

A psychotherapeutic intervention that unites mindfulness training, “third wave” cognitive behavioral therapy (CBT), and positive psychology significantly reduces chronic pain and opioid misuse, new research suggests. In a randomized clinical trial, 250 adults with both opioid misuse and chronic pain received either the intervention, called mindfulness-oriented recovery enhancement (MORE), or supportive psychotherapy. Results showed the … Read more